HBV and HCV Seroprevalence in Rheumatology Patients Using Biological Drugs
Objective: Hepatitis B virus (HBV) and Hepatitis C virus (HCV) infections are a global public health problem. Biological drugs can cause reactivation of HBV infection in patients with chronic HBV carrier or occult HBV infection. Likewise, it is known that it can cause reactivation of HCV infection...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dicle University Medical School
2020-12-01
|
| Series: | Dicle Medical Journal |
| Subjects: | |
| Online Access: | http://diclemedj.org/upload/sayi/79/Dicle%20Med%20J-04421.pdf |